Wordt geladen...
Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression
BACKGROUND: Novel therapies are needed for children with high-risk and relapsed neuroblastoma. We hypothesized that MAPK/ERK kinase (MEK) inhibition with the novel MEK1/2 inhibitor binimetinib would be effective in neuroblastoma preclinical models. METHODS: Levels of total and phosphorylated MEK and...
Bewaard in:
| Gepubliceerd in: | BMC Cancer |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772351/ https://ncbi.nlm.nih.gov/pubmed/26925841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2199-z |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|